These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites. Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002 [TBL] [Abstract][Full Text] [Related]
9. Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients. Kølendorf K; Bojsen J; Deckert T Horm Metab Res; 1983 Jun; 15(6):274-8. PubMed ID: 6409773 [TBL] [Abstract][Full Text] [Related]
10. Portable detectors for 125I-insulin absorption measurement during subcutaneous infusion with portable pumps. Bojsen J; Kølendorf K; Deckert T Phys Med Biol; 1984 Apr; 29(4):395-405. PubMed ID: 6371846 [TBL] [Abstract][Full Text] [Related]
11. Effect of major surgery on absorption rate of NPH insulin injected s.c. Hjortrup A; Madsbad S; Andersen M; Sørensen C Br J Anaesth; 1990 Jun; 64(6):741-2. PubMed ID: 2378778 [TBL] [Abstract][Full Text] [Related]
12. Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs. Jørgensen KH; Hansen AK; Buschard K Diabetes Res Clin Pract; 2000 Dec; 50(3):161-7. PubMed ID: 11106830 [TBL] [Abstract][Full Text] [Related]
13. Absorption and miscibility of regular porcine insulin after subcutaneous injection of insulin-treated diabetic patients. Kølendorf K; Bojsen J; Deckert T Diabetes Care; 1983; 6(1):6-9. PubMed ID: 6341016 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes. Luzio SD; Beck P; Owens DR Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275 [TBL] [Abstract][Full Text] [Related]
15. Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. Pramming S; Lauritzen T; Thorsteinsson B; Johansen K; Binder C Acta Endocrinol (Copenh); 1984 Feb; 105(2):215-20. PubMed ID: 6364670 [TBL] [Abstract][Full Text] [Related]
16. Variability of insulin absorption and insulin action. Heinemann L Diabetes Technol Ther; 2002; 4(5):673-82. PubMed ID: 12450450 [TBL] [Abstract][Full Text] [Related]
17. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Thow JC; Johnson AB; Fulcher G; Home PD Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans. Kang S; Brange J; Burch A; Vølund A; Owens DR Diabetes Care; 1991 Nov; 14(11):942-8. PubMed ID: 1797506 [TBL] [Abstract][Full Text] [Related]
19. Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. Roy B; Chou MC; Field JB J Clin Endocrinol Metab; 1980 Mar; 50(3):475-9. PubMed ID: 6987253 [TBL] [Abstract][Full Text] [Related]
20. Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo). Kølendorf K; Aaby P; Westergaard S; Deckert T Eur J Clin Pharmacol; 1978 Nov; 14(2):117-24. PubMed ID: 363432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]